Overview
Shi Li practices practicing medicine in Guangzhou, China.
Her clinical expertise encompasses Trophoblastic Tumor Placental Site and Renal Cell Carcinoma (RCC).
She is actively involved in clinical research, co-authoring 12 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Shi Li
Is Shi Li a top-rated expert for Trophoblastic Tumor Placental Site?
MediFind is an objective health platform that identifies experts based on real-world data. Shi Li is classified as an Experienced expert for Trophoblastic Tumor Placental Site, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Shi Li participate in research or clinical trials?
Yes. Shi Li has published 12 articles and abstracts on conditions like Trophoblastic Tumor Placental Site. You can view a list of Shi Li's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Renal Cell Carcinoma (RCC)Ms. Li isExperienced. Learn about Renal Cell Carcinoma (RCC).
- Trophoblastic Tumor Placental Site